Los Angeles Capital Management & Equity Research Inc. Invests $411,000 in MedEquities Realty Trust Inc. (MRT) Stock

Los Angeles Capital Management & Equity Research Inc. acquired a new stake in MedEquities Realty Trust Inc. (NYSE:MRT) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 34,980 shares of the financial services provider’s stock, valued at approximately $411,000. Los Angeles Capital Management & Equity Research Inc. owned approximately 0.11% of MedEquities Realty Trust at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MRT. Schwab Charles Investment Management Inc. increased its stake in MedEquities Realty Trust by 372.8% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 320,531 shares of the financial services provider’s stock valued at $3,594,000 after purchasing an additional 252,739 shares in the last quarter. Boston Partners increased its stake in MedEquities Realty Trust by 18.5% in the 2nd quarter. Boston Partners now owns 1,423,929 shares of the financial services provider’s stock valued at $17,970,000 after purchasing an additional 221,911 shares in the last quarter. Russell Investments Group Ltd. increased its stake in MedEquities Realty Trust by 43.0% in the 2nd quarter. Russell Investments Group Ltd. now owns 642,623 shares of the financial services provider’s stock valued at $8,112,000 after purchasing an additional 193,182 shares in the last quarter. American Century Companies Inc. increased its stake in MedEquities Realty Trust by 11.2% in the 3rd quarter. American Century Companies Inc. now owns 1,726,208 shares of the financial services provider’s stock valued at $20,283,000 after purchasing an additional 174,261 shares in the last quarter. Finally, State Street Corp increased its stake in MedEquities Realty Trust by 41.7% in the 2nd quarter. State Street Corp now owns 529,702 shares of the financial services provider’s stock valued at $6,684,000 after purchasing an additional 155,934 shares in the last quarter. 93.19% of the stock is owned by hedge funds and other institutional investors.

In other MedEquities Realty Trust news, CEO John W. Mcroberts acquired 18,000 shares of the firm’s stock in a transaction dated Friday, November 17th. The shares were acquired at an average price of $10.74 per share, for a total transaction of $193,320.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Randy L. Churchey acquired 5,300 shares of the firm’s stock in a transaction dated Monday, November 20th. The shares were acquired at an average price of $10.87 per share, for a total transaction of $57,611.00. Following the acquisition, the director now directly owns 46,776 shares of the company’s stock, valued at $508,455.12. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 23,600 shares of company stock worth $254,129. 2.50% of the stock is owned by insiders.

Shares of MedEquities Realty Trust Inc. (NYSE MRT) remained flat at $$11.22 during trading hours on Friday. 147,620 shares of the company’s stock were exchanged, compared to its average volume of 244,772. The stock has a market cap of $356.30, a price-to-earnings ratio of 10.20 and a beta of -0.75. MedEquities Realty Trust Inc. has a one year low of $10.06 and a one year high of $13.06.

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 29th. Shareholders of record on Wednesday, November 15th were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 7.49%. The ex-dividend date was Tuesday, November 14th. MedEquities Realty Trust’s dividend payout ratio (DPR) is presently 210.01%.

A number of equities research analysts have commented on MRT shares. KeyCorp reiterated a “buy” rating and set a $13.00 target price on shares of MedEquities Realty Trust in a report on Friday, August 25th. Cantor Fitzgerald started coverage on MedEquities Realty Trust in a report on Thursday, August 31st. They set an “overweight” rating and a $14.00 target price on the stock. Capital One Financial started coverage on MedEquities Realty Trust in a report on Monday, October 23rd. They set an “equal weight” rating and a $13.00 target price on the stock. B. Riley reiterated a “buy” rating on shares of MedEquities Realty Trust in a report on Wednesday, November 1st. Finally, Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 target price on the stock in a report on Wednesday, November 15th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $12.83.

COPYRIGHT VIOLATION WARNING: “Los Angeles Capital Management & Equity Research Inc. Invests $411,000 in MedEquities Realty Trust Inc. (MRT) Stock” was originally reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at https://transcriptdaily.com/2017/12/03/los-angeles-capital-management-equity-research-inc-invests-411000-in-medequities-realty-trust-inc-mrt-stock.html.

About MedEquities Realty Trust

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Institutional Ownership by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply